CorMedix IncNASDAQ:CRMD
- LAST PRICE10.3500
- TODAY'S CHANGE (%)-0.6500 (-5.9091%)
- Bid / Lots10.3500/ 7
- Ask / Lots10.3800/ 7
- Open / Previous Close10.8300 / 11.0000
- Day Range
- 52 Week Range
- Volume806,177
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 47277 | 10.75 |
| 09:33 ET | 800 | 10.85 |
| 09:35 ET | 3257 | 10.76 |
| 09:37 ET | 12468 | 10.8399 |
| 09:39 ET | 5404 | 10.85 |
| 09:42 ET | 2300 | 10.9 |
| 09:44 ET | 8400 | 10.83 |
| 09:46 ET | 1050 | 10.77 |
| 09:48 ET | 2150 | 10.82 |
| 09:50 ET | 12147 | 10.79 |
| 09:51 ET | 8400 | 10.845 |
| 09:53 ET | 600 | 10.8852 |
| 09:55 ET | 720 | 10.8225 |
| 09:57 ET | 2140 | 10.77 |
| 10:00 ET | 5837 | 10.775 |
| 10:02 ET | 100 | 10.76 |
| 10:04 ET | 1500 | 10.77 |
| 10:06 ET | 1627 | 10.76 |
| 10:08 ET | 33212 | 10.71 |
| 10:09 ET | 5908 | 10.7173 |
| 10:11 ET | 14569 | 10.71 |
| 10:13 ET | 100 | 10.71 |
| 10:15 ET | 3668 | 10.695 |
| 10:18 ET | 927 | 10.6953 |
| 10:20 ET | 3200 | 10.7186 |
| 10:22 ET | 4002 | 10.725 |
| 10:24 ET | 1100 | 10.7124 |
| 10:26 ET | 4752 | 10.6943 |
| 10:27 ET | 6000 | 10.72 |
| 10:29 ET | 1519 | 10.715 |
| 10:31 ET | 5722 | 10.76 |
| 10:33 ET | 2319 | 10.6902 |
| 10:36 ET | 5142 | 10.755 |
| 10:38 ET | 9730 | 10.7 |
| 10:40 ET | 1944 | 10.745 |
| 10:42 ET | 2591 | 10.76 |
| 10:44 ET | 9538 | 10.7 |
| 10:45 ET | 800 | 10.69 |
| 10:47 ET | 1150 | 10.68 |
| 10:49 ET | 700 | 10.7 |
| 10:51 ET | 10167 | 10.68 |
| 10:54 ET | 1400 | 10.6489 |
| 10:56 ET | 100 | 10.63 |
| 10:58 ET | 12962 | 10.57 |
| 11:00 ET | 5633 | 10.62 |
| 11:02 ET | 200 | 10.63 |
| 11:03 ET | 3768 | 10.64 |
| 11:05 ET | 2976 | 10.64 |
| 11:07 ET | 400 | 10.65 |
| 11:09 ET | 700 | 10.645 |
| 11:12 ET | 20229 | 10.595 |
| 11:14 ET | 4095 | 10.65 |
| 11:16 ET | 105319 | 10.67 |
| 11:18 ET | 1325 | 10.69 |
| 11:20 ET | 2294 | 10.66 |
| 11:21 ET | 9607 | 10.6 |
| 11:23 ET | 1100 | 10.6 |
| 11:25 ET | 3300 | 10.63 |
| 11:27 ET | 2099 | 10.63 |
| 11:30 ET | 1000 | 10.64 |
| 11:32 ET | 200 | 10.67 |
| 11:34 ET | 990 | 10.665 |
| 11:36 ET | 1799 | 10.655 |
| 11:38 ET | 25442 | 10.525 |
| 11:39 ET | 953 | 10.53 |
| 11:41 ET | 500 | 10.53 |
| 11:43 ET | 500 | 10.5462 |
| 11:45 ET | 1100 | 10.53 |
| 11:48 ET | 15382 | 10.47 |
| 11:50 ET | 656 | 10.4 |
| 11:52 ET | 6666 | 10.45 |
| 11:54 ET | 700 | 10.465 |
| 11:56 ET | 310 | 10.48 |
| 11:57 ET | 150 | 10.465 |
| 11:59 ET | 5960 | 10.505 |
| 12:01 ET | 2261 | 10.5 |
| 12:03 ET | 6323 | 10.43 |
| 12:06 ET | 100 | 10.435 |
| 12:08 ET | 1054 | 10.44 |
| 12:10 ET | 4092 | 10.44 |
| 12:12 ET | 1241 | 10.46 |
| 12:14 ET | 1550 | 10.4585 |
| 12:15 ET | 1000 | 10.465 |
| 12:17 ET | 300 | 10.47 |
| 12:19 ET | 511 | 10.47 |
| 12:21 ET | 700 | 10.475 |
| 12:24 ET | 2981 | 10.49 |
| 12:26 ET | 2204 | 10.49 |
| 12:28 ET | 6166 | 10.5 |
| 12:30 ET | 2191 | 10.49 |
| 12:32 ET | 900 | 10.4542 |
| 12:33 ET | 200 | 10.43 |
| 12:35 ET | 800 | 10.45 |
| 12:37 ET | 1412 | 10.42 |
| 12:39 ET | 6090 | 10.395 |
| 12:42 ET | 292 | 10.38 |
| 12:44 ET | 5301 | 10.332 |
| 12:46 ET | 4862 | 10.3343 |
| 12:48 ET | 8971 | 10.3 |
| 12:50 ET | 10403 | 10.3307 |
| 12:53 ET | 361 | 10.325 |
| 12:57 ET | 1400 | 10.27 |
| 01:00 ET | 4647 | 10.26 |
| 01:02 ET | 900 | 10.26 |
| 01:04 ET | 6257 | 10.24 |
| 01:06 ET | 4987 | 10.224 |
| 01:08 ET | 862 | 10.239 |
| 01:09 ET | 1977 | 10.235 |
| 01:11 ET | 1588 | 10.25 |
| 01:13 ET | 900 | 10.2443 |
| 01:15 ET | 590 | 10.235 |
| 01:18 ET | 2581 | 10.22 |
| 01:20 ET | 10317 | 10.23 |
| 01:22 ET | 700 | 10.25 |
| 01:24 ET | 400 | 10.245 |
| 01:26 ET | 1100 | 10.22 |
| 01:27 ET | 645 | 10.1892 |
| 01:29 ET | 878 | 10.21 |
| 01:31 ET | 1999 | 10.21 |
| 01:33 ET | 889 | 10.2114 |
| 01:36 ET | 340 | 10.226 |
| 01:38 ET | 7097 | 10.172 |
| 01:42 ET | 4859 | 10.19 |
| 01:44 ET | 700 | 10.175 |
| 01:45 ET | 943 | 10.2 |
| 01:47 ET | 4068 | 10.211 |
| 01:49 ET | 3492 | 10.22 |
| 01:51 ET | 9676 | 10.225 |
| 01:54 ET | 450 | 10.225 |
| 01:56 ET | 2999 | 10.195 |
| 01:58 ET | 1064 | 10.23 |
| 02:00 ET | 1000 | 10.215 |
| 02:02 ET | 500 | 10.21 |
| 02:03 ET | 511 | 10.2 |
| 02:05 ET | 7973 | 10.205 |
| 02:07 ET | 3614 | 10.24 |
| 02:09 ET | 4009 | 10.29 |
| 02:12 ET | 1400 | 10.27 |
| 02:14 ET | 9422 | 10.3446 |
| 02:16 ET | 500 | 10.31 |
| 02:18 ET | 13467 | 10.27 |
| 02:20 ET | 2969 | 10.32 |
| 02:23 ET | 2281 | 10.31 |
| 02:25 ET | 1191 | 10.29 |
| 02:27 ET | 400 | 10.29 |
| 02:30 ET | 5213 | 10.31 |
| 02:32 ET | 1200 | 10.31 |
| 02:34 ET | 1755 | 10.315 |
| 02:36 ET | 427 | 10.315 |
| 02:38 ET | 700 | 10.315 |
| 02:39 ET | 1385 | 10.315 |
| 02:41 ET | 2020 | 10.3599 |
| 02:43 ET | 1624 | 10.37 |
| 02:45 ET | 100 | 10.35 |
Nov 4, 2024
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium, from 8:30AM ET on Monday Nov 04, 2024 by Dow Jones
8:30AM ET on Monday Nov 04, 2024 by Dow Jones
Oct 31, 2024
DJ CorMedix Is Maintained at Buy by Needham, from 6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
6:21AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 30, 2024
DJ CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk, from 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones*DJ CorMedix 3Q Loss/Shr 5c >CRMD, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:30AM ET on Wednesday Oct 30, 2024 by Dow JonesCorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update, from 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 667.4M | -12.9x | --- |
Zevra Therapeutics Inc | 482.0M | -5.1x | --- |
Elite Pharmaceuticals Inc | 553.0M | 30.3x | --- |
Cipla Ltd | 14.3B | 0.0x | --- |
Eton Pharmaceuticals Inc | 270.2M | -46.9x | --- |
Incannex Healthcare Inc | 41.3M | -2.0x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Chief Executive Officer, Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Chief Clinical Strategy and Operations Officer
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Legal Officer and Corporate Secretary
- Beth Kaufman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $667.4M |
|---|---|
Revenue (TTM) | $12.3M |
Shares Outstanding | 60.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.58 |
EPS | $-0.80 |
Book Value | $1.28 |
P/E Ratio | -12.9x |
Price/Sales (TTM) | 54.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -415.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
